Status:
COMPLETED
Sensor Validation Study - Quality Assurance
Lead Sponsor:
PMD Solutions
Conditions:
Respiratory Rate
Eligibility:
All Genders
Up to 18 years
Brief Summary
The respiratory rate is an important parameter in clinical medicine. It is defined as the number of breaths per minute. Currently this is measured at the bedside in clinical practice by counting the b...
Eligibility Criteria
Inclusion
- ≥ 18 Years
- Have a BMI ≥35
- For the sub-group analysis at least 5 subjects with a BMI 35-49 and at least 5 BMI \> 50 will be needed
- Are willing to voluntarily sign a statement of informed consent to participate in this investigation
Exclusion
- Allergic to medical grade skin adhesive
- Continuous oral long term steroid use. To be free from oral steroid use this is defined as not using oral steroids in the 4 weeks previous to enrolment
- Patients under the influence of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
- Any disorder, including cognitive dysfunction, which would affect the ability to accurately complete questionnaires and freely give full informed consent
Key Trial Info
Start Date :
July 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 7 2018
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03306537
Start Date
July 28 2017
End Date
September 7 2018
Last Update
March 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Alexandra Hospital
Portsmouth, United Kingdom, PO6 3LY